 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.6.1
- Ribose-phosphate diphosphokinase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
Ribose activation
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + D-ribose 5-phosphate = AMP + 5-phospho-alpha-D-ribose 1-diphosphate
|
 |
 |
 |
 |
 |
ATP
|
+
|
D-ribose 5-phosphate
|
=
|
AMP
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
5-phospho-alpha-D-ribose 1-diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
protein complex
|
3 terms
|
 |
|
Biological process
|
carbohydrate metabolic process
|
16 terms
|
 |
|
Biochemical function
|
nucleotide binding
|
12 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochem J
401:39-47
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site.
|
|
S.Li,
Y.Lu,
B.Peng,
J.Ding.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
PRPP (phosphoribosylpyrophosphate) is an important metabolite essential for
nucleotide synthesis and PRS (PRPP synthetase) catalyses synthesis of PRPP from
R5P (ribose 5-phosphate) and ATP. The enzymatic activity of PRS is regulated by
phosphate ions, divalent metal cations and ADP. In the present study we report
the crystal structures of recombinant human PRS1 in complexes with SO4(2-) ions
alone and with ATP, Cd2+ and SO4(2-) ions respectively. The AMP moiety of ATP
binds at the ATP-binding site, and a Cd2+ ion binds at the active site and in a
position to interact with the beta- and gamma-phosphates of ATP. A SO4(2-) ion,
an analogue of the activator phosphate, was found to bind at both the
R5P-binding site and the allosteric site defined previously. In addi-tion, an
extra SO4(2-) binds at a site at the dimer interface between the ATP-binding
site and the allosteric site. Binding of this SO4(2-) stabilizes the
conformation of the flexible loop at the active site, leading to the formation
of the active, open conformation which is essential for binding of ATP and
initiation of the catalytic reaction. This is the first time that structural
stabilization at the active site caused by binding of an activator has been
observed. Structural and biochemical data show that mutations of some residues
at this site influence the binding of SO4(2-) and affect the enzymatic activity.
The results in the present paper suggest that this new SO4(2-)-binding site is a
second allosteric site to regulate the enzymatic activity which might also exist
in other eukaryotic PRSs (except plant PRSs of class II), but not in bacterial
PRSs.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.Krissinel
(2011).
Macromolecular complexes in crystals and solutions.
|
| |
Acta Crystallogr D Biol Crystallogr, 67,
376-385.
|
 |
|
|
|
|
 |
J.H.Lim,
H.J.Lee,
Y.K.Pak,
W.H.Kim,
and
J.Song
(2011).
Organelle stress-induced activating transcription factor-3 downregulates low-density lipoprotein receptor expression in Sk-Hep1 human liver cells.
|
| |
Biol Chem, 392,
377-385.
|
 |
|
|
|
|
 |
L.J.Alderwick,
G.S.Lloyd,
A.J.Lloyd,
A.L.Lovering,
L.Eggeling,
and
G.S.Besra
(2011).
Biochemical characterization of the Mycobacterium tuberculosis phosphoribosyl-1-pyrophosphate synthetase.
|
| |
Glycobiology, 21,
410-425.
|
 |
|
|
|
|
 |
A.P.Lucarelli,
S.Buroni,
M.R.Pasca,
M.Rizzi,
A.Cavagnino,
G.Valentini,
G.Riccardi,
and
L.R.Chiarelli
(2010).
Mycobacterium tuberculosis phosphoribosylpyrophosphate synthetase: biochemical features of a crucial enzyme for mycobacterial cell wall biosynthesis.
|
| |
PLoS One, 5,
e15494.
|
 |
|
|
|
|
 |
A.P.de Brouwer,
H.van Bokhoven,
S.B.Nabuurs,
W.F.Arts,
J.Christodoulou,
and
J.Duley
(2010).
PRPS1 mutations: four distinct syndromes and potential treatment.
|
| |
Am J Hum Genet, 86,
506-518.
|
 |
|
|
|
|
 |
X.Jiang,
J.Zhang,
M.Xia,
W.Qiu,
H.Wang,
D.Zhao,
and
Y.Wang
(2010).
Role of activating transcription factor 3 (ATF3) in sublytic C5b-9-induced glomerular mesangial cell apoptosis.
|
| |
Cell Mol Immunol, 7,
143-151.
|
 |
|
|
|
|
 |
X.Liu,
D.Han,
J.Li,
B.Han,
X.Ouyang,
J.Cheng,
X.Li,
Z.Jin,
Y.Wang,
M.Bitner-Glindzicz,
X.Kong,
H.Xu,
A.Kantardzhieva,
R.D.Eavey,
C.E.Seidman,
J.G.Seidman,
L.L.Du,
Z.Y.Chen,
P.Dai,
M.Teng,
D.Yan,
and
H.Yuan
(2010).
Loss-of-function mutations in the PRPS1 gene cause a type of nonsyndromic X-linked sensorineural deafness, DFN2.
|
| |
Am J Hum Genet, 86,
65-71.
|
 |
|
|
|
|
 |
M.Barenco,
D.Brewer,
E.Papouli,
D.Tomescu,
R.Callard,
J.Stark,
and
M.Hubank
(2009).
Dissection of a complex transcriptional response using genome-wide transcriptional modelling.
|
| |
Mol Syst Biol, 5,
327.
|
 |
|
|
|
|
 |
A.Jiménez,
M.A.Santos,
and
J.L.Revuelta
(2008).
Phosphoribosyl pyrophosphate synthetase activity affects growth and riboflavin production in Ashbya gossypii.
|
| |
BMC Biotechnol, 8,
67.
|
 |
|
|
|
|
 |
H.M.Chen,
L.Wang,
and
S.R.D'Mello
(2008).
Inhibition of ATF-3 expression by B-Raf mediates the neuroprotective action of GW5074.
|
| |
J Neurochem, 105,
1300-1312.
|
 |
|
|
|
|
 |
S.Maallem,
A.Wierinckx,
J.Lachuer,
M.H.Kwon,
and
M.L.Tappaz
(2008).
Gene expression profiling in brain following acute systemic hypertonicity: novel genes possibly involved in osmoadaptation.
|
| |
J Neurochem, 105,
1198-1211.
|
 |
|
|
|
|
 |
A.P.de Brouwer,
K.L.Williams,
J.A.Duley,
A.B.van Kuilenburg,
S.B.Nabuurs,
M.Egmont-Petersen,
D.Lugtenberg,
L.Zoetekouw,
M.J.Banning,
M.Roeffen,
B.C.Hamel,
L.Weaving,
R.A.Ouvrier,
J.A.Donald,
R.A.Wevers,
J.Christodoulou,
and
H.van Bokhoven
(2007).
Arts syndrome is caused by loss-of-function mutations in PRPS1.
|
| |
Am J Hum Genet, 81,
507-518.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|